Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...

While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the ...

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, ...

Mylan’s $465 million proposed settlement with CMS may not cover the amount of money it allegedly saved by improperly classifying EpiPens as a generic drug, according to research published Monday in ...

Mylan NV said on Thursday, Aug. 25, it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary ...

(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy ...

The maker of EpiPens will begin selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues -- and looming competition threatens its ...

After facing fierce backlash, drugmaker Mylan last week agreed to offer discounts to patients who use its EpiPens. "As a mother, I can assure you, the last thing that we would ever want is no one to ...

Heather Bresch will face the proverbial lash from Congress on Wednesday over the escalating cost of Mylan NV’s EpiPen. Her boss won’t. Robert J. Coury acquired the rights to sell the emergency allergy ...

The company's CEO will defend her company's increase in EpiPen pricing. — -- Mylan Pharmaceuticals CEO Heather Bresch is expected to defend her company’s increase in EpiPen pricing when she ...

Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for a two-pack, making it ...

NEW YORK (AP) – Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine. The company said Monday that its U.S.